Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 10 of 10 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 07/28/19
Due: 07/28/20
Phase: N/A
Priority: Normal
Start: 01/30/19
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 01/16/20
End: 07/30/23
Due: 07/30/24
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 01/12/25
Due: 01/12/26
Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer
Phase: N/A
Priority: Normal
Start: 01/16/24
End: 01/31/26
Due: 01/31/27
Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save Study
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 08/01/22
End: 10/01/24
Due: 10/01/25
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 06/27/19
End: 05/17/21
Due: 05/17/22